Protara Therapeutics Balance Sheet (2013-2026)

Reported Financials

Protara Therapeutics Quarterly Balance Sheet

Periods 53 quarters

Latest Sep 2026

Protara Therapeutics reported total assets of $0.16B and total liabilities of $0.02B for the quarter ended Sep 2026, up 8.2% year over year. This balance sheet covers 53 quarters of results from Sep 2013 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026	Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	35.72M	25.44M	33.82M	47.50M	24.13M	21.04M	33.98M	33.77M	39.59M	52.23M	89.58M	51.76M	162.80M	91.46M	31.50M	12.55M	49.66M	14.74M	17.08M	25.15M
Short-term InvestmentsInvestments (Current)	55.51M	62.16M	64.64M	48.82M	60.24M	65.58M	46.38M	40.27M	25.99M	2.99M	65.77M	29.74M	7.49M	32.90M	90.72M	120.12M	105.90M	121.05M	125.42M	101.90M
Cash & Current Investments	91.23M	87.59M	98.46M	96.32M	84.37M	86.61M	80.36M	74.03M	65.58M	55.22M	155.35M	81.50M	170.29M	124.36M	122.22M	132.67M	155.55M	135.79M	142.49M	127.05M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets	1.88M	3.10M	2.63M	2.35M	1.78M	8.01M	3.91M	3.78M	3.13M	2.69M	2.63M	3.58M	1.86M	2.17M	2.88M	2.97M	3.95M	4.21M	3.66M	2.62M
Current Assets	93.11M	90.69M	101.09M	98.67M	86.15M	94.62M	84.27M	77.81M	68.71M	57.91M	92.21M	85.08M	172.16M	126.53M	125.09M	135.64M	159.50M	140.00M	146.15M	129.67M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	1.72M	1.68M	1.64M	1.66M	1.59M	1.52M	1.44M	1.40M	1.30M	1.21M	1.19M	1.11M	1.03M	0.99M	0.91M	0.83M	0.76M	0.67M	1.32M	1.58M
Long-Term Investments	39.47M	30.89M	14.35M	10.76M	17.89M	2.89M								33.15M	23.39M	0.96M	42.34M	41.64M	19.36M	16.03M
Goodwill	29.52M	29.52M	29.52M	29.52M
Intangibles
Goodwill & Intangibles	29.52M	29.52M	29.52M	29.52M
Long-Term Deferred Tax
Other Non-Current Assets	1.61M	1.53M	1.56M	1.48M	0.75M	1.33M	3.63M	3.69M	2.94M	0.75M	0.75M	0.75M	3.27M	0.75M	0.75M	0.75M	2.95M	5.98M	5.92M	6.21M
Non-Current Assets	79.48M	70.57M	53.79M	49.92M	27.14M	11.79M	10.88M	10.65M	10.25M	10.22M	9.43M	9.01M	9.30M	42.03M	31.84M	8.99M	49.96M	51.93M	29.94M	26.87M
Assets	172.60M	161.26M	154.88M	148.59M	113.29M	106.41M	95.14M	88.47M	78.95M	68.13M	101.65M	94.09M	181.45M	168.56M	156.93M	144.64M	209.47M	191.92M	176.09M	156.54M
Liabilities
Current Liabilities
Accounts Payables	0.95M	0.54M	0.39M	0.46M	1.59M	4.08M	1.85M	2.50M	2.43M	0.97M	1.39M	2.30M	4.43M	2.31M	5.30M	4.50M	3.47M	4.03M	4.66M	4.86M
Notes Payables
Payables	0.95M	0.54M	0.39M	0.46M	1.59M	4.08M	1.85M	2.50M	2.43M	0.97M	1.39M	2.30M	4.43M	2.31M	5.30M	4.50M	3.47M	4.03M	4.66M	4.86M
Accumulated Expenses	2.49M	1.45M	2.22M	2.35M	3.24M	1.40M	2.13M	3.31M	2.73M	3.53M	3.23M	5.27M	5.41M	3.54M	3.26M	4.19M	6.23M	3.63M	7.37M	8.22M
Other Accumulated Expenses	0.25M	0.08M	0.12M	0.18M	0.18M	0.11M	0.10M	0.08M	0.18M	0.27M	0.12M	0.37M	0.14M	0.23M	0.33M	0.33M	0.28M	0.18M	0.53M	1.34M
Current Deferred Revenue
Current Deferred Tax LiabilityCurrent Deferred Tax
Total Current Liabilities	4.30M	2.86M	3.49M	3.71M	5.74M	6.41M	4.93M	6.78M	6.15M	5.50M	5.65M	8.64M	10.96M	7.02M	9.76M	9.91M	10.94M	8.92M	13.32M	14.39M
Non-Current Liabilities
Preferred Stock Liabilities	476.28M							1.00M					1.00M	2.38M	2.38M	2.38M		1.00M	1.00M
Operating Leases	6.38M	6.16M	5.93M	5.70M	5.47M	5.23M	4.98M	4.74M	4.48M	4.23M	3.95M	3.66M	3.36M	3.06M	2.75M	2.44M	2.12M	1.79M	1.46M	1.13M
Other Non-Current Liabilities														10,118.38M	10,118.38M	10,118.38M		2,325.37M	2,325.37M
Total Non-Current Liabilities														-10,108.31M	-10,105.87M	-10,106.04M		-2,314.66M	-2,310.59M
Total Liabilities	10.68M	9.02M	9.43M	9.41M	11.21M	11.64M	9.92M	11.51M	10.63M	9.73M	9.60M	12.30M	14.32M	10.08M	12.51M	12.35M	13.06M	10.72M	14.78M	15.52M
Shareholder's Equity
Total Debt
Common Equity	161.91M	152.24M	145.46M	139.18M	102.08M	94.77M	85.23M	76.96M	68.32M	58.41M	92.05M	81.79M	167.13M	158.48M	144.42M	132.29M	196.41M	181.21M	161.31M	141.02M
Liabilities and Shareholders Equity	172.60M	161.26M	154.88M	148.59M	113.29M	106.41M	95.14M	88.47M	78.95M	68.13M	101.65M	94.09M	181.45M	168.56M	156.93M	144.64M	209.47M	191.92M	176.09M	156.54M
Retained Earnings	-94.01M	-104.77M	-113.31M	-121.00M	-159.96M	-169.01M	-180.30M	-190.16M	-200.38M	-211.48M	-220.99M	-232.21M	-244.98M	-256.89M	-271.85M	-285.11M	-302.42M	-320.20M	-341.87M	-363.56M
Preferred Shares					0.01M			0.01M					0.00	0.00	0.00	0.00	0.00	0.00	0.00

Protara Therapeutics Balance Sheet API

Pull Protara Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TARA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "TARA", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=TARA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Protara Therapeutics TARA Balance Sheet (2013-2026)

Protara Therapeutics Quarterly Balance Sheet

Protara Therapeutics Balance Sheet API

Create an account

Sign In

Reset Password